Retraction
CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits A β1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway
Paper Information
Record ID:
47607
Author(s):
Publication Date:
September 08, 2022
Retraction Date:
June 28, 2023
(2.4 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (3)
3
Total Citations0
Post-Retraction2
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer’s Disease
Giulia Bivona, Matilda Iemmolo, Giulio Ghersi
International Journal of Molecular Sciences
Open Access
Published: May 2023
19 citations
19 citations
55 days before retraction
Retracted: CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits A<i>β</i><sub>1-42</sub>‐Induced SH‐SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
178 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025